Gabitril label change
Cephalon is removing Filmtab from Gabitril (tiagabine) label because name of the tablet coating process is trademarked by Abbott. Change only pertains to product name; manufacturing process for the antiepileptic drug has not changed, Cephalon says in Aug. 27 "Dear Healthcare Professional" letter. Cephalon purchased Gabitril from Abbott in November 2000 (1"The Pink Sheet" Nov. 6, 2000, p. 9)
You may also be interested in...
Cephalon plans to develop Gabitril for indications outside of epilepsy, the company said after announcing the acquisition of the product from Abbott Nov. 1.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials